Who are Boston Bioprocess's investors?

Boston Bioprocess's investors include Clear Current Capital, FTW Ventures, Lever VC, Siddhi Capital.

How much funding has Boston Bioprocess raised?

Boston Bioprocess has disclosed $6.3M raised across 1 round.

Where is Boston Bioprocess headquartered?

Boston Bioprocess is headquartered in Champaign, US.

Boston Bioprocess

Champaign, US · Founded 2022 · Delaware corporation · 4 known investors

Find your way into Boston Bioprocess

Paths you didn't know you had: your email and LinkedIn already hold routes to the Boston Bioprocess team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Boston Bioprocess provides fermentation and bioprocess development services—including scale-up across 1.5L to 1,500L vessels, downstream process development, regulatory guidance, and tech transfer to CMOs—for companies bringing biomanufactured products to production. It also offers software and AI-driven process intelligence for lab execution, batch record management, scheduling, and results analysis.

AI & Machine Learning Biotech SaaS

Founders & leadership

Michael TaiNamed on SEC filing

Ted NetlandNamed on SEC filing

Board

James Caffyn Board directorPartner at Lever VC

Investors · 4

Clear Current Capitallisted by Clear Current CapitalVero Beach

FTW Ventureslisted by FTW VenturesSan Francisco · $100K – $500K

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Lever VClisted by Lever VCNew York · $100K – $5M

How we know: Lever VC's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Siddhi Capitallisted by Siddhi CapitalMeridian

How we know: Siddhi Capital's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$6.3M disclosed across 1 round · 2024

▶$6.3MraisedJul 2024 · 14 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Michael TaiExecutive Officer, Director
James CaffynDirector
Ted NetlandExecutive Officer, Director

Offering amount: $6.5M
Amount sold: $6.3M
First sale: Jul 2024
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

Companies working in the same space as Boston Bioprocess.

Frequently asked questions

What does Boston Bioprocess do?: Boston Bioprocess provides fermentation and bioprocess development services—including scale-up across 1.5L to 1,500L vessels, downstream process development, regulatory guidance, and tech transfer to CMOs—for companies bringing biomanufactured products to production. It also offers software and AI-driven process intelligence for lab execution, batch record management, scheduling, and results analysis.
Who are Boston Bioprocess's investors?: Boston Bioprocess's investors include Clear Current Capital, FTW Ventures, Lever VC, Siddhi Capital.
How much funding has Boston Bioprocess raised?: Boston Bioprocess has disclosed $6.3M raised across 1 round.
Where is Boston Bioprocess headquartered?: Boston Bioprocess is headquartered in Champaign, US.